News Formal

Novo Nordisk to discontinue Levemir insulin in U.S. market

  • 📰 SaltWire Network
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 63%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

Explore stories from Atlantic Canada.

Celebrating Wild Caraway: Taste of Nova Scotia's Restaurant of the Year | SaltWire - Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, citing manufacturing constraints, reduced patient access and available alternatives.

The announcement comes eight months after Novo said it would cut U.S. list prices for several of its insulin products next year, including a 65% reduction in the list price of Levemir, in response to mounting political pressure over insulin prices. The announcement followed a similar one by Eli Lilly.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 45. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Novo Nordisk to discontinue Levemir insulin in U.S. marketThe Danish drugmaker said supply disruptions would start in mid-January, followed by discontinuation of the Levemir injection pen in April and of Levemir...
ソース: YahooFinanceCA - 🏆 47. / 63 続きを読む »

Factbox-Corporate America weighs business impact of new weight-loss drugsDrugs in a class known as GLP-1 such as Novo Nordisk's Wegovy and Ozempic as well as Eli Lilly's Mounjaro have been shown to help control blood sugar and...
ソース: YahooFinanceCA - 🏆 47. / 63 続きを読む »